From September 23-24, pharmaceutical executives are meeting in Philadelphia to discuss current trends, strategic insights, and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics.
The process of bringing a new drug to market can be lengthy and complex, requiring significant R&D, access to specialized manufacturing equipment, and the expertise to navigate technical and regulatory concerns. With rising manufacturing costs and restricted in-house capabilities, companies are increasingly relying on external manufacturing experts to provide fast and cost-effective drug development.
From September 23-24, the American Pharma Outsourcing Summit will address key industry trends and challenges in pharmaceutical outsourcing, bringing together top industry executives to discuss current trends, strategic insights, and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics. Attendees will hear first-hand case studies and walk away with strategic insights on how to reduce time to market, optimize manufacturing quality, ensure success in project execution, and leverage new technologies. Leaders discussing external manufacturing and quality at this year’s meeting in Philadelphia include:
Ratna Shekhar, Head, External Site Operations, Takeda
“Ensuring Operational Excellence in Your Outsourced Operations”
Jim Fries, CEO, Rx-360
“Ensuring GMP and Data Integrity When Working with Third-Party Manufacturing Partners”
Suyamburam Sathasivam, AVP and HEad, External Manufacturing, Biologics, Sun Pharmaceutical Industries Ltd.
“Examining Successful Technology Transfer Processes for Biologics”
Jeff McLean, Director, TPT
“Digitize to Thrive: Brilliant Manufacturing and Quality as a Better Way Forward”
Prashant S. Savle, Ph.D., Director, Commercialization Projects, Global Procurement, Merck & Co.
“Managing End-to-End Supply Chains of Small Molecule APIs, Intermediates and Drug Products: Ensuring Safety, Quality, Minimizing Cost Increases and Assuring Security of Supply”
Mark Fromhold, Ph.D., Senior Director, Pharmaceutical Operations, Alder Biopharmaceuticals Inc.
“Establishing Trust and Developing Risk-Sharing Partnerships with Suppliers”
Other core learning objectives:
Network with peers, connect with exhibitors, and hear from top industry influencers as we explore how to maximize efficiency while remaining compliant in an ever-evolving environment. This invitation-only summit provides a unique opportunity to explore innovation in production methods and evolving technologies.
Join us to:
If you are interested in attending, sponsoring, or speaking at the American Pharma Outsourcing Summit, applications are open now. Please submit your request here.
Highlights from previous events and this year’s agenda can be found on the American Pharma Outsourcing Summit website.